LOGAN CAROLYN J 4
4 · SALIX PHARMACEUTICALS LTD · Filed Apr 22, 2013
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Award
Common Stock
2013-04-18$48.70/sh+94,199$4,587,491→ 707,812 total
Holdings
- 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying) - 400,000(indirect: by GRAT)
Common Stock
Footnotes (2)
- [F1]Represents a restricted stock award which vests annually in four equal installments beginning January 1, 2014, subject to continued employment.
- [F2]Options are 100% vested.